Retro Biosciences
Retro Biosciences raises $1B Growth at $2B valuation
Quick Facts
Retro Biosciences: Growth Funding Round
Retro Biosciences has successfully raised $1B in Growth funding, reaching a valuation of $2B.
Company Overview
Extending healthy human lifespan
Funding Details
The Growth round was led by Sandro Salsano, with participation from Y Combinator.
Company Information
- Headquarters: San Mateo, CA
- Founded: 2021
- Employees: 150+
- Category: Biotech
Investment
Retro Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Sandro Salsano: Verified investor in Growth
- Y Combinator: Verified investor in Growth
Key Investors
About the Author
Related Company Reports
Arthrosi Therapeutics raises $153M Series E at $800M valuation
Arthrosi Therapeutics raises $153M in Series E at $800M valuation. Developing next-generation gout treatment drug for chronic conditions...
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
